Flu Vis Statement 2024. — on march 5, the fda’s vaccines and related biological products advisory committee (vrbpac) met to discuss and make recommendations on the vaccine. 2024 to 2025 flu programme summary.
— the dates of current and past editions of vaccine information statements (viss) and other vaccine information materials that preceded viss are listed in these. Trivalent flu vaccines are formulated to protect against three flu viruses (an a(h1n1) virus, an a(h3n2) virus, and a b/victoria virus).
